Cargando…
Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan
BACKGROUND: The effectiveness of fremanezumab in treating migraine has been demonstrated in randomized controlled trials. However, real-world study results are still limited. METHODS: We conducted a single-center, observational study that included patients with episodic migraine (EM) and chronic mig...
Autores principales: | Suzuki, Shiho, Suzuki, Keisuke, Shiina, Tomohiko, Haruyama, Yasuo, Hirata, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359132/ https://www.ncbi.nlm.nih.gov/pubmed/37483436 http://dx.doi.org/10.3389/fneur.2023.1220285 |
Ejemplares similares
-
Exploring the contributing factors to multiple chemical sensitivity in patients with migraine
por: Suzuki, Keisuke, et al.
Publicado: (2022) -
Investigating the relationships between the burden of multiple sensory hypersensitivity symptoms and headache-related disability in patents with migraine
por: Suzuki, Keisuke, et al.
Publicado: (2021) -
Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational study
por: Cullum, Christopher Kjaer, et al.
Publicado: (2023) -
Central Sensitization in Migraine: A Narrative Review
por: Suzuki, Keisuke, et al.
Publicado: (2022) -
Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses
por: Fiedler‐Kelly, Jill, et al.
Publicado: (2020)